Drug details

Ridaura (auranofin)

type of DMARDs, Gold Compounds

Ridaura (auranofin) is a gold preparation used in the management of adults with active (classical or definite) rheumatoid arthritis who have not responded to adequate trials of conventional anti-inflammatory therapy. Ridaura might also be of benefit in patients with psoriatic arthritis.

The drug is often used to treat Psoriatic arthritis .

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• nausea,
• loss of appetite,
• itching,
• vomiting,
• easy bruising,
• pale skin,
• shortness of breath,
• wheezing,
• unusual tiredness,
• unusual bleeding (nosebleeds, bleeding gums),
• puffy eyes,
• swelling in your ankles or feet,
• dry cough,
• purple or red spots under your skin,
• severe skin rash,
• sudden chest pain,
• urine that looks foamy
• blood in your urine, and
• black, bloody, or tarry stools,
• sever or ongoing diarrhea,

The following drugs are related to Ridaura, either as a replacement or used together:

• Amjevita (adalimumab-atto)
• Lodine (etodolac)
• Etodolac XR (etodolac extended release)
• Plaquenil (hydroxychloroquine)
• Inflectra (infliximab-dyyb intravenous injection)
• Rheumatrex (methotrexate tablets)
• PrismaSol Solution (sterile hemofiltration hemodiafiltration solution)